Rep. Gilbert Ray Cisneros, Jr. bought Vaxcyte (PCVX)
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31) · $1K–$15K · traded May 13, 2026
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- May 13, 2026
- Disclosed
- Jun 8, 2026
- Days to disclose
- 26
- Asset type
- Stock
- As filed
- Vaxcyte, Inc. - Common Stock
- Industry
- Biotechnology · Healthcare
Other trades in this filing
All of Cisneros's trades →- Jun 8, 2026$1K–$15K
$1K–$15K · Traded Jun 2, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Bought Ligand Pharmaceuticals LGND
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Bought The Cooper Companies COO
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
Traded 6 days before earnings - Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$15K–$50K
$15K–$50K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Bought Texas Capital Bancshares TCBI
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Sold (partial) W. R. Berkley WRB
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Bought Perella Weinberg Partners PWP
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Bought Arcutis Biotherapeutics ARQT
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$250K–$500K
Bought New York City, NY Transitional Finance Authority Bonds
$250K–$500K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
Traded 6 days before earnings - Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
$1K–$15K · Traded May 29, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Sold (partial) MACOM Technology Solutions Holdings MTSI
$1K–$15K · Traded May 22, 2026 · disclosed Jun 8, 2026
- Jun 8, 2026$1K–$15K
Sold (partial) W. R. Berkley WRB
$1K–$15K · Traded May 19, 2026 · disclosed Jun 8, 2026
Recent Congress trades in PCVX
- Sep 4, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Jul 16, 2026 · disclosed Sep 4, 2026 · filed 50 days later
- Jun 8, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded May 12, 2026 · disclosed Jun 8, 2026
- May 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Apr 28, 2025 · disclosed May 6, 2025
- May 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Apr 15, 2025 · disclosed May 6, 2025
- May 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Apr 14, 2025 · disclosed May 6, 2025
- Apr 11, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded Mar 5, 2025 · disclosed Apr 11, 2025
- Jan 20, 2023$1K–$15K
Company context for PCVX
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
PCVX: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
PCVX: Financial results
Filed 8-K for an event or period dated 2026-11-04. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
PCVX: Material agreement · New financial obligation · Other company developments
Filed 8-K for an event or period dated 2026-10-06. Material agreement; New financial obligation; Other company developments.
1 congressional household disclosed purchases in the past 90 days. See the trades
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.